Timetech Formulations Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 29-06-2024
- Paid Up Capital ₹ 4.65 Cr
as on 29-06-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 6.55 Cr
as on 29-06-2024
- Revenue %
(FY 2016)
- Profit -513.99%
(FY 2016)
- Ebitda -1226.09%
(FY 2016)
- Net Worth -55.88%
(FY 2016)
- Total Assets -80.73%
(FY 2016)
About Timetech Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 4.65 Cr.
The company currently has active open charges totaling ₹6.55 Cr.
Gouth Prabhanj, Nagamani Gouth, and Nagaraju Gouth serve as directors at the Company.
- CIN/LLPIN
U24230TG1996PLC023460
- Company No.
023460
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Mar 1996
- Date of AGM
29 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Timetech Formulations Limited offer?
Timetech Formulations Limited offers a wide range of products and services, including Company Law & Labour Law Consultants, Statutory Compliance Services, Health Conditions, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Timetech Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagaraju Gouth  | Managing Director | 08-Mar-1996 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gouth Prabhanj | Additional Director | 11-May-2015 | Current |
| Nagamani Gouth | Director | 01-Feb-2002 | Current |
Financial Performance of Timetech Formulations.
Timetech Formulations Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 513.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Timetech Formulations?
In 2016, Timetech Formulations had a promoter holding of 52.00% and a public holding of 48.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Timetech Lifesciences LimitedActive 10 years 3 monthsGouth Prabhanj, Nagamani Gouth and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 27 Oct 2009 | ₹6.00 Cr | Open |
Asrec (India) Limited Creation Date: 31 Mar 2005 | ₹4.00 M | Open |
Asrec (India) Limited Creation Date: 03 Jun 2003 | ₹1.00 M | Open |
How Many Employees Work at Timetech Formulations?
Unlock and access historical data on people associated with Timetech Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Timetech Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Timetech Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
